Related Experiment Videos
Therapy of congestive heart failure in elderly persons
1Hebrew Hospital Home, Bronx, New York, USA.
Insights
Treatment guidelines for elderly patients with congestive heart failure (CHF) emphasize measuring left ventricular ejection fraction (LVEF). Tailored therapies address underlying causes and precipitating factors for improved outcomes.
Area of Science:
- Cardiology
- Geriatrics
- Pharmacology
Background:
- Congestive heart failure (CHF) is a significant health concern in the elderly population.
- Left ventricular ejection fraction (LVEF) is a key indicator in assessing CHF severity and guiding treatment.
- Identifying and managing underlying and precipitating causes of CHF is crucial for effective patient care.
Purpose of the Study:
- To outline evidence-based treatment strategies for elderly individuals diagnosed with congestive heart failure.
- To differentiate therapeutic approaches based on the patient's left ventricular ejection fraction (LVEF) status (abnormal vs. normal).
- To provide guidance on medication selection and sequencing for refractory CHF cases.
Main Methods:
- Review and synthesis of current clinical guidelines and evidence for CHF management in the elderly.
- Categorization of treatment recommendations based on LVEF measurements.
- Stepwise therapeutic algorithms detailing medication additions for persistent symptoms.
Main Results:
- For CHF with abnormal LVEF: initial treatment includes low sodium diet, diuretics, ACE inhibitors. Subsequent additions: digoxin, then isosorbide dinitrate/hydralazine, followed by beta-blockers. Calcium channel blockers are contraindicated.
- For CHF with normal LVEF: initial treatment includes low sodium diet, diuretics, ACE inhibitors. Subsequent options: beta-blockers, isosorbide dinitrate/hydralazine, or calcium channel blockers. Digoxin is not recommended in sinus rhythm.
- For patients intolerant to ACE inhibitors: losartan is recommended regardless of LVEF.
Conclusions:
- A systematic, LVEF-guided approach is essential for managing CHF in the elderly.
- Medication sequencing and avoidance of specific drug classes (e.g., calcium channel blockers in abnormal LVEF) are critical.
- Alternative therapies like losartan provide options for patients with ACE inhibitor intolerance.
Abstract:
LVEF should be measured in all elderly persons with CHF Underlying causes and precipitating causes of CHF should be treated. Persons with CHF associated with abnormal LVEF should be treated with a low sodium diet, diuretics, and ACE inhibitors. If CHF persists, digoxin should be added. If CHF still persists, isosorbide dinitrate plus hydralazine should be added. If CHF still persists, a beta blocker should also be added. However, calcium channel blockers should not be used. Persons with CHF associated with normal LVEF should be treated with a low sodium diet, diuretics, and ACE inhibitors. If CHF persists, a beta blocker, isosorbide dinitrate plus hydralazine, or a calcium channel blocker should be added to the therapeutic regimen. If sinus rhythm is present, digoxin should not be used. Persons with CHF and abnormal or normal LVEF unable to tolerate ACE inhibitors should be treated with losartan.